{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-021210","form_type":"8-K","ticker":"BCDA","cik":"0000925741","company_name":"BioCardia, Inc.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.849439+00:00","generated_at":"2026-05-18T21:48:50.843750+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"BioCardia granted US Patent No. 12,311,127 for Helix catheter delivery system","bullets":["Patent covers radial and trans-endocardial delivery catheter for biologic therapies.","Protects helical needle-tipped catheter platform; cited as safest and most efficient approach.","Helix system underlies CardiAMP Cell Therapy program for ischemic cardiomyopathies and refractory angina.","CEO notes work toward separate approvals of the therapy and the delivery system."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-021210","json":"https://secwatch.observer/filing/0001437749-25-021210.json","markdown":"https://secwatch.observer/filing/0001437749-25-021210.md","text":"https://secwatch.observer/filing/0001437749-25-021210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/925741/000143774925021210/0001437749-25-021210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/925741/000143774925021210/bcda20250625_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T21:48:50.843750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}